Miltenyi CGT Summit 2024 Panel Discussion - Academic CGT development from hematology to solid tumors

Miltenyi Cell and Gene Therapy Summit 2024 Panel Discussion - Academic CGT development from hematology to solid tumors
Held at the Miltenyi Cell and Gene Therapy Summit 2024 and moderated by Georgia Fodelinaki (Miltenyi Biotec), join panelists David Reardon (Dana Farber Cancer Institute, USA), Hyoung Jin Kang (Seoul National University Hospital, South Korea), and Marion Subklewe (University Hospital of Munich, Germany) as they discuss key challenges academic centers encounter in establishing and conducting clinical trials for cell therapies in hematological malignancies and solid tumors.
Click through to hear more information from your colleagues' experiences and challenges, find relevant upcoming events, or sign up for our newsletter to connect with your community. - Empower cells, empower lives